Diomede Luisa, Romeo Margherita, Rognoni Paola, Beeg Marten, Foray Claudia, Ghibaudi Elena, Palladini Giovanni, Cherny Robert A, Verga Laura, Capello Gian Luca, Perfetti Vittorio, Fiordaliso Fabio, Merlini Giampaolo, Salmona Mario
1 Department of Molecular Biochemistry and Pharmacology, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri ," Milan, Italy .
2 Amyloid Research and Treatment Center , Foundation IRCCS Policlinico San Matteo, Pavia, Italy .
Antioxid Redox Signal. 2017 Sep 20;27(9):567-582. doi: 10.1089/ars.2016.6848. Epub 2017 Mar 3.
The knowledge of the mechanism underlying the cardiac damage in immunoglobulin light chain (LC) amyloidosis (AL) is essential to develop novel therapies and improve patients' outcome. Although an active role of reactive oxygen species (ROS) in LC-induced cardiotoxicity has already been envisaged, the actual mechanisms behind their generation remain elusive. This study was aimed at further dissecting the action of ROS generated by cardiotoxic LC in vivo and investigating whether transition metal ions are involved in this process. In the absence of reliable vertebrate model of AL, we used the nematode Caenorhabditis elegans, whose pharynx is an "ancestral heart."
LC purified from patients with severe cardiac involvement intrinsically generated high levels of ROS and when administered to C. elegans induced ROS production, activation of the DAF-16/forkhead transcription factor (FOXO) pathway, and expression of proteins involved in stress resistance and survival. Profound functional and structural ROS-mediated mitochondrial damage, similar to that observed in amyloid-affected hearts from AL patients, was observed. All these effects were entirely dependent on the presence of metal ions since addition of metal chelator or metal-binding 8-hydroxyquinoline compounds (chelex, PBT2, and clioquinol) permanently blocked the ROS production and prevented the cardiotoxic effects of amyloid LC. Innovation and Conclusion: Our findings identify the key role of metal ions in driving the ROS-mediated toxic effects of LC. This is a novel conceptual advance that paves the way for new pharmacological strategies aimed at not only counteracting but also totally inhibiting the vicious cycle of redox damage. Antioxid. Redox Signal. 27, 567-582.
了解免疫球蛋白轻链(LC)淀粉样变性(AL)中心脏损伤的潜在机制对于开发新疗法和改善患者预后至关重要。尽管已经设想了活性氧(ROS)在LC诱导的心脏毒性中起积极作用,但其产生背后的实际机制仍不清楚。本研究旨在进一步剖析体内心脏毒性LC产生的ROS的作用,并研究过渡金属离子是否参与这一过程。由于缺乏可靠的AL脊椎动物模型,我们使用了线虫秀丽隐杆线虫,其咽部是“原始心脏”。
从严重心脏受累患者中纯化的LC本身会产生高水平的ROS,当给予秀丽隐杆线虫时会诱导ROS产生、DAF-16/叉头转录因子(FOXO)途径的激活以及参与应激抵抗和存活的蛋白质的表达。观察到与AL患者淀粉样变影响的心脏中观察到的类似的由ROS介导的严重功能和结构线粒体损伤。所有这些效应完全依赖于金属离子的存在,因为添加金属螯合剂或金属结合的8-羟基喹啉化合物(螯合树脂、PBT2和氯碘羟喹)会永久阻断ROS的产生并防止淀粉样LC的心脏毒性作用。创新与结论:我们的研究结果确定了金属离子在驱动LC的ROS介导的毒性作用中的关键作用。这是一个新的概念进展,为旨在不仅对抗而且完全抑制氧化还原损伤恶性循环的新药理学策略铺平了道路。《抗氧化剂.氧化还原信号》27,567 - 582。